Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIV
Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test whether chronic administration of the drug acipimox will
improve hyperlipidemia and insulin sensitivity among HIV infected patients experiencing
highly active antiretroviral therapy (HAART) associated metabolic disturbances.